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A novel visible light responsive nanosystem for cancer treatment 
M. Martínez-Carmona,
a,b*
 D. Lozano,
a,b
 A. Baeza,
a,b
 M. Colilla
a,b
 and M. Vallet-Regí
a,b* 
A novel singlet-oxygen sensitive drug delivery nanocarrier able to release their cargo after exposure to visible (Vis) light of 
a common lamp is presented. This nanodevice is based on mesoporous silica nanoparticles (MSN) decorated with 
porphyrin-caps grafted via reactive oxygen species (ROS)-cleavable linkages. In presence of Vis light the porphyrin-
nanocaps produce singlet oxygen molecules that break the sensitive-linker, which triggers pore uncapping and therefore 
allows the release of the entrapped cargo (topotecan, TOP). This new system takes advantage of the non-toxicity and 
greater penetration capacity of Vis radiation and a double antitumor effect due to the drug release and the ROS 
production. In vitro tests with HOS osteosarcoma cancer cells reveal that TOP is able to be released in a controlled fashion 
inside the tumor cells. This research work constitutes a proof of concept that opens up promising expectations in the 
seeking for new alternatives for the treatment of cancer.  
Introduction 
Due to its unique properties, especially its great loading 
capacity, mesoporous silica nanoparticles (MSN) have proven 
to be great candidates as nanocarriers for drug delivery 
purposes.
1–6
 In recent years scientists have not only been 
focused on loading as much drug as possible but also on 
achieving a premature zero release system to avoid the 
appearance of undesirable side effects.
7
 For this purpose 
several smart drug delivery nanodevices capable of releasing 
their cargo only after exposition to an internal or external 
stimulus have been designed.
8
 Among the different stimuli 
(pH, enzymes, ultrasounds, magnetic fields, etc.), light is an 
excellent means to control the properties of materials and 
small molecules for many applications, especially when it is 
used for the controlled release of pharmacological agents for 
therapeutic purposes. The reason why light has emerged as 
one of the most promising alternatives is that its application 
can be spatial and timed controlled with ease.
9
 
Since ultraviolet (UV) light has the highest power and can 
break bonds more easily than other radiations, it has been by 
far the most widely used radiation to trigger drug release from 
stimuli-responsive devices.
10–13
 However, UV light has 
substantial drawbacks for in vitro and in vivo experiments and 
therefore for current medical applications. The first one 
concerns its low tissue penetrability (attenuation down to 1% 
occurs for light wavelengths of 250-280 nm at around 40 µm 
depth)
14
 since many biological molecules absorb these 
energetic wavelengths directly. The second one is related to its 
toxicity. UV light causes progressive damage to human 
surrounded skin mediated by free radical generation
15
, 
destruction of vitamins A,
16
 and C,
17,18
, collagen damage
19
 and 
even worse genetic damage.
20
 Therefore, systems able to 
respond to visible (Vis) light rather than to UV offer a less 
harmful alternative.
21
 Vis light exhibits a more effective tissue 
penetrability (attenuation down to 1 % occurs up to 1.2 µm at 
800 µm), which is ideal for medical applications. Besides, Vis 
light has a more innocuous nature due to a smaller energetic 
content. However, this lack of power is also responsible for its 
inefficiency when breaking bonds, and because of that, to date 
only a few visible light responsive devices have been 
reported.
22,23
 However It has been observed that this energy is 
already enough to activate some photosensitizers in the 
production of reactive oxygen species (ROS).
24,25
 ROS are 
highly reactive, especially with organic compounds that 
contain double bonds. It has been reported the spontaneous 
cleavage of aminoacrylates (β-enamino esters) following 2+2 
cycloaddition reactions of singlet oxygen with olefins for the 
site-specific release of bioactive molecules.
26
  
Herein, we propose and demonstrate an innovative approach 
to design a new Vis light-responsive drug delivery nanosystem. 
To this aim, the pore outlets of drug-loaded MSN are blocked 
via sol-gel chemistry by grafting silylated porphyrin nanocaps 
incorporating ROS-cleavable bonds, which have been carefully 
designed and whose synthesis has been optimized in this work. 
The irradiation of the nanosystem with Vis light would 
stimulate porphyrin nanocaps, generating ROS species able to 
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break the sensitive bonds and therefore triggering pore 
uncapping and allowing drug release. The results derived from 
the current work constitute a significant advance in the 
nanomedicine field with potential application in cancer 
treatment.  
Experimental 
Reagents 
Tetraethylorthosilicate (TEOS, 98%), n-
cetyltrimethylammonium bromide (CTAB, ≥ 99%), sodium 
hydroxide (NaOH, ≥ 98%), ammonium nitrate (NH4NO3, ≥ 98%), 
propiolic acid (95%),4-piperidineacetic acid hydrochloride 
(PAH), (3-aminopropyl) triethoxysilane (APTES, ≥ 98%), N,N’- 
dicyclohexylcarbodiimide (DCC, 99%), N-hydroxysuccinimide 
(NHS, 98%), phosphate-buffered saline (PBS, 10x), 
phosphotungstic acid hydrate (PTA, reagent grade), 
tris(bipyridine)ruthenium(II) chloride ([Ru(bipy)3]Cl2), 
topotecan (TOP) and calcein (CAL) were purchased from 
Sigma-Aldrich (St. Louis, USA). 5,10,15,20-(Tetra-3-
hydroxyphenl) porphyrin was purchased from Porphychem 
(Dijon, France). All other chemicals were purchased from 
Panreac Química SLU (Castellar del Valles, Barcelona, Spain) 
inc: absolute ethanol (EtOH), acetone, dimethyl sulfoxide 
(DMSO), tetrahydrofuran (THF), etc. All reagents were used as 
received without further purification. Ultrapure deionized 
water with resistivity of 18.2 MΩ was obtained using a 
Millipore Milli-Q plus system (Millipore S.A.S, Molsheim, 
France). 
  
Characterisation techniques 
Powder X-Ray Diffraction (XRD) experiments were performed 
in a Philips X’Pert diffractometer equipped with Cu Kα 
radiation (wavelength 1.5406 Å) (Philips Electronics NV, 
Eindhoven, Netherlands). XRD patterns were collected in the 
2 range between 0.6° and 8° with a step size of 0.02° and 
counting time of 5 s per step. Thermogravimetric analysis 
(TGA) were performed in a Perkin Elmer Pyris Diamond 
TG/DTA (California, USA), with 5 ᵒC min
-1
 heating ramps, from 
room temperature (RT) to 600 ᵒC. Fourier transform infrared 
spectroscopy (FTIR) was carried out in a Nicolet (Thermo Fisher 
Scientific, Waltham, MA, USA) Nexus spectrometer equipped 
with a Goldengate attenuated total reflectance (ATR) 
accessory (Thermo Electron Scientific Instruments LLC, 
Madison, WI USA). Morphology, mesoestructural order and 
nanoparticles functionalization were studied by High 
Resolution Transmission Electron Microscopy (HRTEM) with a 
JEOL JEM 3000F instrument operating at 300 kV, equipped 
with a CCD camera (JEOL Ltd., Tokyo, Japan). Sample 
preparation was performed by dispersing in ethanol and 
subsequent deposition onto carbon-coated copper grids. A 1% 
PTA solution (pH 7.0) was used as staining agent in order to 
visualize the organic coating around MSN. 
To determine the evolution of the size and surface charge of 
nanoparticles by dynamic light scattering (DLS) and zeta (-
potential measurements, respectively, a Zetasizer Nano ZS 
(Malvern Instruments, United Kingdom) equipped with a 633 
nm “red” laser 7 was used. DLS measurements were directly 
recorded in ethanolic colloidal suspensions. -potential 
measurements were recorded in aqueous colloidal 
suspensions. For this purpose 1 mg of nanoparticles was added 
to 10 mL of solvent followed by 5 min of sonication to obtain a 
homogeneous suspension. In both cases measurements were 
recorded by placing 1 mL of suspension (0.1 mg mL
-1
) in 
DTS1070 disposable folded capillary cells (Malvern 
Instruments). The textural properties of the materials were 
determined by N2 adsorption porosimetry by using a 
Micromeritics ASAP 2020 (Micromeritics Co., Norcross, USA). 
To perform the N2 measurements, 20-30 mg of each sample 
was previously degassed under vacuum for 24 h at 40 ᵒC. The 
surface area (SBET) was determined using the Brunauer-
Emmett-Teller (BET) method and the pore volume (VP) was 
estimated from the amount of N2 adsorbed at a relative 
pressure around 0.97. The pore size distribution between 0.5 
and 40 nm was calculated from the adsorption branch of the 
isotherm by means of the Barrett-Joyner-Halenda (BJH) 
method. The mesopore size (DP) was determined from the 
maximum of the pore size distribution curve. Nuclear magnetic 
resonance (NMR) measurements were performed in a Bruker 
AV250 spectrometer (Karlsruhe, Germany).  
 
Synthesis of mesoporous silica nanoparticles (MSN) 
Bare MSN, denoted as MSN, were synthesized by the modified 
Stöber method using TEOS as silica source in the presence of 
CTAB as structure directing agent. Briefly, 1 g of CTAB, 480 mL 
of H2O and 3.5 mL of NaOH (2 M) were added to a 1,000 mL 
round bottom flask. The mixture was heated to 80 ᵒC and 
magnetically stirred at 600 rpm. When the reaction mixture 
was stabilized at 80 ᵒC, 5 mL of TEOS were added dropwise at 
0.33 mL min
-1
 rate. The obtained white suspension was stirred 
for further 2h at 80 ᵒC. The reaction mixture was centrifuged 
and washed three times with water and ethanol. Then the 
surfactant was removed by ionic exchange by soaking 1 g of 
nanoparticles in 500 mL of a NH4NO3 solution (10 mg mL
- 1
) in 
ethanol (95%) at 65 ᵒC overnight under magnetic stirring. The 
nanoparticles were collected by centrifugation, washed twice 
with water and twice with ethanol and stored in ethanol. 
 
Synthesis of singlet oxygen-labile linker 
The synthesis of the singlet oxygen-labile linker was carried out 
in several steps and always under N2 atmosphere and in the 
absence of light. Firstly to a 0.5 mL of an ice cooled and stirred 
solution of porphyrin (25 mg, 0.036 mmol) and propiolic acid 
(12 µL, 0.18 mmol) in dry THF, a solution of 0.5 mL of N,N'-
dicyclohexylcarbodiimide (DCC, 37.6 mg, 0.18 mmol) and 4- 
dimethylaminopyridine (DMAP, 2 mg, 0.016 mmol) was added 
dropwise during 15 min. Reaction mixture was then stirred 
overnight at RT.  
At the same time, a mixture of 4-piperidineacetic acid 
hydrochloride (26 mg), DCC (7.28 mg) and NHS (4 mg) was 
dissolved in 2 mL of dry DMSO and left to react for 5 h before 
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adding APTES (34 µL, 0.18 mmol) and leaving it to react 
overnight.  
Finally both solutions were mixed during 24 h to get the 
desired linker.  
 
[Ru(bipy)3]Cl2/topotecan (TOP)/calcein (CAL) loading  
25 mg of MSN was placed in a topaz vial and then, 3 mL of a 14 mg 
mL
-1
 EtOH solution of [Ru(bipy)3]Cl2 (RBP), or an aqueous solution of 
CAL or TOP (6 or 9 mg mL
-1
, respectively) was added and the 
suspension was stirred at room temperature for 24 h. The sample 
was centrifuged and the nanoparticles were resuspended in 500 mL 
of EtOH and placed in a 3-necked round flask. 
 
Attachment of the singlet oxygen-labile linker on the MSN 
25 mg of MSN was placed in a 3-necked round bottom flask 
and dried under vacuum. Then, 5 mL of dry toluene was added 
and the flask was placed in an ultrasonic bath for a better 
suspension of the particles. Subsequently, the solution of the 
singlet oxygen-labile linker previously prepared was added 
keeping the reaction in the darkness under a nitrogen 
atmosphere at 80 ᵒC for 24 h. Then, the reaction mixture was 
centrifuged and washed three times with DMSO, two times 
with EtOH and two times with water. Finally, the product was 
resuspended in 3 mL of PBS 1x. 
 
In vial cargo release assays  
To investigate the light-responsive drug release performance 
of V-MSN, TOP was chosen as a potent cytotoxic drug and in 
vial time-based fluorescence release experiments in presence 
and absence of visible light (20 W bulb) were carried out. Two 
batches of 400 µL of 8.33 mg mL
-1
 of TOP-loaded V-MSN (V-
MSN@TOP) suspension were placed in a vial. One of them was 
exposed to Vis light irradiation for 30 min while orbital stirring. 
The other batch was treated under similar conditions but 
without light irradiation. 
For the release experiments, the procedure reported by Bein 
and coworkers was used.
27
 Thus, 170 µL of each nanoparticles 
suspension was filled into a reservoir cap sealed with a dialysis 
membrane (molecular weight cut-off 12,000 g mol
-1
), allowing 
released dye molecules to pass into the fluorescence cuvette 
(which was completely filled with PBS 1x) while the relatively 
large particles were held back. Experiments were performed at 
a temperature of 37 °C. The amount of drug released was 
determined by fluorescence measurements of the solutions 
recorded on a PTI QuantaMaster 400 system featuring a JYF-
FLUOROMAX-4 compact spectrofluorimeter single grating 
excitation and emission monochromator with a 
photomultiplier detector (PMT R928P) and an automated four-
position thermostated cuvette-holder (FL-1011) (PTI, Photon 
Technology International, HORIBA Jobin Yvon GmbH, 
Germany). For temperature settings, a MTB-IFI-156-5251 
refrigerated bath circulator with a peltier was used. TOP was 
excited with λexc = 400 nm and showed a maximum of emission 
at λem = 540 nm (excitation slit 0.38 mm, emission slit 0.38 
mm, integration 1s).  
 
In vitro cell culture 
Cell culture studies were performed using HOS cells derived 
from a human osteosarcoma. The tested MSN (50 μg mL
-1
) 
were placed into each well of 24-well plates after cell seeding. 
HOS cells were then plated at a density of 20.000 cells cm
2
 in 
Dulbecco’s modified Eagle’s medium (DMEM, Sigma Chemical 
Company), respectively, containing 10% of heat-inactivated 
fetal bovine serum and 1% penicillin– streptomycin at 37 ᵒC in 
a humidified atmosphere of 5% CO2, and incubated for 
different times. Some wells contained no MSN as controls. 
 
Cell viability 
Cell proliferation was assessed after HOS cell incubation in 24-
well plates with MSN for 24 and 48h. The tested MSN (50 μg 
mL
-1
) were placed during 2 h. Cells were then exposed or not 
(same conditions) to visible light irradiation for 30 min with 
orbital stirring. Cells were washed with PBS three times. At 24 
h and 48 h, Alamar Blue solution (AbD Serotec, Oxford, UK) at 
10% (v/v) was added to the cell culture. 4 h thereafter, 
absorbance was measured using excitation and emission 
wavelengths of 540 and 620 nm, respectively. 
 
Fluorescence microscopy 
Cells were incubated with the CAL loaded MSN (V-MSN@CAL) 
(50μg mL
-1
) for 2h in serum-free culture medium. Cells were 
then exposed or not (same conditions) to Vis light irradiation 
for 30 min under orbital stirring.  Then, the medium was 
withdrawn and cells were washed with PBS three times and 
the medium was replaced. At 1h, cells were fixed with ethanol. 
Fluorescence microscopy images were taken to evaluate 
intracellular calcein release essay. Green channel was used to 
locate the calcein release in an Evos FL Cell Imaging System 
equipped with tree Led Lights Cubes (lEX (nm); lEM (nm)): 
DAPY (357/44; 447/60), GFP (470/22; 525/50), RFP (531/40; 
593/40) from AMG (Advance Microscopy Group). 
Results and discussion 
Vis light-responsive mesoporous silica nanoparticles (V-MSN) 
were composed of porphyrin caps, able to generate singlet 
oxygen by irradiation of Vis light, covalently grafted to the 
surface of MCM-41 type MSN by (β-enamino esters), a singlet 
oxygen-labile linker. The synthesis and characterization of 
MSN had been previously reported,
28
 and their high loading 
capacity was took in advance for loading TOP. Then, the pores 
were closed with a Vis light-responsive system to avoid 
premature release (Figure 1). 
 
Synthesis of the visible light-responsive system 
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The synthesis of the photosensitive system was carried out in 
several steps and always under N2 atmosphere and absence of 
light (Figure 2). 
Firstly, the singlet oxygen-labile linker was synthesized, and 
the structure of each reaction intermediate was confirmed by 
1
H-NMR. The HO-porphyrin was coupled with propiolic acid 
using the Steglich esterification reaction. The presence of a 
singlet at 3.792 ppm characteristic of the propiolic acid 
confirmed that the obtained product was “A” (S1). In the 
reaction between APTES and 4-piperidineacetic acid 
hydrochloride (PAH), the  
 
Figure 1. Schematic depiction illustrating the operation mechanism of the 
nanodevice developed in this work.  
 
appearance of a new signal at 7.965 ppm due to amide 
formation between the amino group of the APTES and the 
carboxylic acid of the PAH was observed, giving place to 
product “B” (S2). Finally, after the reaction between products 
“A” and “B” the complete singlet oxygen-labile linker was 
obtained. A proof of this fact was the disappearance of the 
singlet signal corresponding to the alkyne protons and the 
appearance of two doublets due to the protons of the formed 
double bond (S3). Due to the complexity of the product, and to 
ensure that the assignment was correct, a parallel and simpler 
reaction was performed where “A” was reacted with PAH 
(“C”). In this case the appearance of the double bonds (S4) and 
their relation through a COSY spectrum (S5) were better 
observed. 
 
Figure 2. Scheme of a) synthesis of singlet oxygen-labile linker and b) attachment 
of the synthetized linker on the MSN. 
 
In order to evaluate the sensitive nature of this double bond to 
oxidation by singlet oxygen, the resulted compound was 
irradiated with a desk lamp for 30 min. The reaction of olefins 
with singlet oxygen was monitored by the decrease of olefinic 
proton peaks in the 
1
H-NMR spectra (Figure 3). 
Once again we compared this response with that obtained for 
the simpler system “C” to visualize the bond rupture in an 
easier way (S6). 
Once the formation and functionality of the singlet oxygen-
labile linker was confirmed it was used to decorate the MSN 
surface by refluxing in dry toluene for 12 h in the darkness, 
producing the functionalized particles V-MSN.  
 
Figure 3. 1H-NMR spectra of the photo-oxidation of the singlet oxygen-labile 
linker. 
 
The resulting material was deeply characterized by different 
techniques. The change from a clean FTIR spectrum in the 
1500–2000 cm
-1
 range of MSN to the presence of several 
bands at 1624 cm
-1
 and 1454 cm
-1
 due to the amide bond 
formation and the C=C stretching of the aromatic rings  
corroborated the functionalization (S7).
29
 The difference 
between TGA measurements of V-MSN and MSN indicated a 
functionalization degree of 17%.  
The textural properties of the nanoparticles, mainly the 
surface area (SBET), pore volume (VP) and pore diameter (DP), 
derived from the treatment of N2 adsorption measurement 
data, experienced noticeable reduction after surface 
decoration. Thus the SBET decreases from 1116 m
2
 g
-1
 for MSN 
to 458 m
2
 g
-1
 for V-MSN. The initial VP of MSN dropped from 
1.05 cm
3
 g
-1
 to 0.22 cm
3
 g
-1
 for V-MSN. Finally, the DP also 
suffers a decrease from 2.9 nm for MSN to 1.9 nm for V-MSN.  
The -potential value of the nanoparticles in water 
experienced a noticeable change from -34.6 ± 0.01 for MSN to 
-20.7 ± 0.04 for V-MSN due to a decrease in the number of 
surface silanol groups. The disappearance of two of the 
characteristics signals (11 and 20) of the XRD patters of MSN in 
the coated nanoparticles (S8)  may be also ascribed to the 
partial filling of the mesopore channels by the 
functionalization agent, as reported elsewhere.
30,31
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TEM images of MSN showed a honeycomb mesoporous 
arrangement typical of MCM-41 (Figure 4). 
Grafting of the photolinker did not affect the mesostructural 
order of V-MSN. The morphology of the nanoparticles was also 
preserved, showing spherical particles in both cases. Finally, 
the transition from a smooth (MSN) to a rough (V-MSN) 
particle surface, due to the capping shell was clearly observed 
(Figure 4). The average diameter of the nanosystems, 
estimated from the measurement of 20 nanoparticles was ca. 
110 nm and 130 nm for MSN and V-MSN, respectively, with a 
relative error of ca. 10%. 
 
 
 
Figure 4. TEM images of MSN and V-MSN. Samples were stained with 1% PTA. 
 
 
Response to light 
The first step was to check if after being anchored to the 
nanoparticle the linker remained sensitive to the action of Vis 
light. For this purpose, and due to the lack of solubility of 
porphyrin in water, 10 mg of V-MSN were weighed, suspended 
in 2 mL of DMSO and divided into 2 vials. One was exposed to 
light from a lamp for 30 min with orbital stirring while the 
second was exposed to the same conditions but protected 
from light as a control. Afterwards, both samples were 
centrifuged. A clearly colored supernatant was observed due 
to the release of the porphyrin in the case of the sample 
subjected to light and a colourless supernatant for the sample 
that remained in darkness (S9a). 
After proving the Vis light-responsive behaviour, the 
effectiveness of the capping was studied. Hence 25 mg of MSN 
were loaded with [Ru(bipy)3]Cl2 as the fluorophore for 24 h. 
Subsequently, the particles were capped with the singlet 
oxygen-labile linker as previously described, affording (V-
MSN@RBPY). Two batches of V-MSN@RBPY were suspended 
in water and one of them was exposed to irradiation for 30 
min under stirring. The other batch was treated under similar 
conditions but without light irradiation. Then, 170 µL of each 
suspension was filled into a reservoir cap sealed with a dialysis 
membrane, allowing released dye molecules to pass into the 
fluorescence cuvette (which was completely filled with PBS at 
pH 7.4). The amount of fluorophore released was determined 
by fluorescence measurements of the solutions, (λex = 451 nm, 
λem = 619 nm). The dye released for the irradiated and non-
irradiated V-MSN@RBPY sample is shown in S9b showing a 
remarkable fluorescence increase in the case of the 
illuminated sample once the experiment was concluded (S9c).  
Afterwards the experiment was repeated but in this case using 
V-MSN@TOP nanoparticles. The estimated amount of TOP 
loaded into the nanosystem was found to be 5.3% in weight, 
as determined from the differences between the fluorescence 
measurements of the initial and the recovered filtrate 
solutions. In this case, the drug release was monitored by 
fluorescence excitation spectroscopy under continuous 
settings during 18 h (Figure 5).  
 
 
 
 
 
Figure 5. In vial drug release profiles from V-MSN@TOP in the absence of light 
(darkness) and upon visible light irradiation (light). 
 
Release profiles can be adjusted to first-order kinetic model by 
introducing an empirical non-ideality factor (δ) to give the 
following equation:
32
  
 
𝑌 =  𝐴(1 − 𝑒−𝑘𝑡)𝛿  
 
being Y the percentage of TOP
 
released at time t, A the 
maximum amount of drug released (in percentage), and k, the 
release rate constant. The values for δ are comprised between 
1 for materials that obeys first-order kinetics, and 0, for 
materials that release the loaded cargo in the very initial time 
of test. The parameters of the kinetic fitting shown in Figure 5 
(R
2
 = 0.990) indicate that, whereas the maximum amount of 
TOP
 
released is practically the totality of the loaded drug after 
light irradiation, almost negligible is released under darkness 
conditions.  
After Vis light irradiation the δ value was 0.62, pointing to a 
near first order kinetics with certain contribution of an initial 
burst release of the entrapped molecules. On the contrary, 
nanoparticles not exposed to light, exhibited a δ value of 0.27, 
indicating that the small amount of TOP released could be due 
to the release of TOP located within uncapped channels and 
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not in the mesopores, whose release was successfully 
hindered by the capping of the pore entrances with the 
porphyrin-derivatized linker. Actually, the total cargo release 
was almost 10-fold higher for irradiated V-MSN@TOP 
nanoparticles than for non-irradiated ones, which was 
associated to a k value more than ten times greater in 
irradiated sample. This finding can be explained by the 
cleavage of the visible-light breakable linkages of the pore 
capping agent after irradiation, which would trigger the 
removal of the porphyrin nanocaps and would allow the 
departure of the entrapped molecules. 
 
In vitro cytotoxicity evaluation 
First of all, we confirmed that exposure of HOS cells to 30 min 
of Vis light irradiation induce a significant decrease (15-20%) in 
cell viability in presence of V-MSN. No differences in viability 
were observed when HOS cells without V-MSN were exposed 
to visible light irradiation (results not shown) in the same 
conditions. After that, we studied the cytotoxicity of the 
system. HOS cells were cultured for 2 h with the nanoparticles 
(50 µg mL
-1
) loaded or not with TOP, V-MSN(@TOP), and then 
washed to eliminate the non-internalized particles. After that, 
part of the cells were irradiated with Vis light for 30 min while 
the others remained in darkness. Vis light irradiation only 
produces a 15% of death in HOS cells that contain drug-free V-
MSN at 24 h of cell culture, probably due to the production of 
ROS
33
 (Figure 6a). While Vis light irradiation of V-MSN@TOP 
induced a significant decreased in HOS viability at 24 h (30%) 
and 48 h (50%) of cell culture. (Figure 6b). The effect of free 
TOP has not been evaluated due to its known inactivation 
under neutral conditions.
31,34,35
 
 
Figure 6. HOS viability in presence or absence of Vis light irradiation (30 min) (a) 
with V-MSN at 24 h of cell culture and (b) with V-MSN@TOP (50 µg mL-1) at 24h 
and 48h of cell culture after presence or absence of visible light irradiation (30 
min), measured by Alamar Blue solution. Results are mean ± SE of three 
independent experiments performed in triplicate. p <0.05 vs corresponding 
control (student's t-test). 
 
 
Intracellular calcein release essay 
It is well known that one of the major challenges when 
designing nanodevices is that some drugs are not able to cross 
the cell membrane and therefore are locked inside the 
endosomes what greatly limit their effectiveness. Our system 
has porphyrin as a cap so that it is able to produce ROS that 
favours the drug endosome escape and the cytoplasm reach.
36
  
To probe that, V-MSN were loaded with CAL (V-MSN@CAL), 
that as has been studied
37,38
 is a membrane impermeable 
molecule, and incubated with HOS cells for 2h. The media 
were changed and the samples showed a perinuclear location 
of the nanoparticles that seems to indicate the V-MSN@CAL 
uptaken by the cells. After 24h the cells exhibited a dot-like 
pattern indicating that CAL was still inside the nanoparticles 
(Figure 7a).  
However, 1h after the photoactivation the green fluorescence 
was through the entire cell proving unequivocally, that the 
nanogates of the pores were opened and the CAL escape from 
the endosome. (Figure 7b). 
 
 
 
 
Figure 7. Fluorescence microscopy images of HOS cells incubated with V-
MSN@CAL loaded before (a) and after (b) light irradiation.  
 
Conclusions 
In conclusion, we have successfully proved a novel 
nanomaterial able to transport topotecan and release it in 
response to visible light irradiation. In this device the 
porphyrin acts both as cap and bond breaker trigger via photo-
unclick chemistry. Almost 99% of the cargo is released after 18 
h after being submitted to 30 min of irradiation with very low 
intensity light. Besides the action of the drug itself the 
generation of ROS favours the antitumor effect of the system. 
The cytotoxic capacity of this system was evaluated in vitro 
against tumour cell lines showing an excellent performance as 
it was able to transform the diseased cells into apoptotic cells 
using a very low particle dose.  
This demonstrates that our drug delivery system can be used 
to efficiently transport membrane impermeable cargos into 
the cell. 
Since the release can be triggered by visible light, the two main 
ultraviolet light drawbacks, low penetrability and harmfulness, 
are overcome. This proof of concept reveals the tremendous 
potential of our system as a valuable tool for its application in 
the spatial-temporal release of not only drugs but also other 
bioactive molecules. Therefore it is envisioned as a new 
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alternative for the treatment of cancer and many other 
diseases. 
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